Please login to the form below

Not currently logged in
Email:
Password:

lampalizumab

This page shows the latest lampalizumab news and features for those working in and with pharma, biotech and healthcare.

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway

Trials of Roche's new blindness candidate now underway. Lampalizumab in phase III for age-related maculardegeneration. ... Roche has started enrolling patients into phase III trials of lampalizumab for dry age-related macular degeneration (AMD) - a major

Latest news

  • Roche moves eye drug lampalizumab into phase III Roche moves eye drug lampalizumab into phase III

    Roche moves eye drug lampalizumab into phase III. It could be the first treatment for geographic atrophy. ... Sandra Horning, head of global product development and chief medical officer at Roche, said: “ Lampalizumab has the potential to represent a

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

Porterhouse Medical provides medical and scientific communication services to the pharmaceutical industry across the globe, with a focus on solutions...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics